FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 269

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
CGC Nasdaq Canopy Growth Corporation 2830
CGEM Nasdaq Cullinan Therapeutics, Inc. 2830
CGEN Nasdaq Compugen Ltd. 2830
CGTX Nasdaq Cognition Therapeutics, Inc. 2830
CHGCY Over the counter Chugai Pharmaceutical Co., Ltd. 2830
CLDX Nasdaq Celldex Therapeutics, Inc. 2830
CLLS Nasdaq Cellectis S.A. 2830
CLNN Nasdaq Clene Inc. 2830
CLX New York The Clorox Company 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CNSP Nasdaq CNS Pharmaceuticals, Inc. 2830
COCP Nasdaq Cocrystal Pharma, Inc. 2830
CPHI NYSE American China Pharma Holdings, Inc. 2830
CPIX Nasdaq Cumberland Pharmaceuticals Inc. 2830
CRBP Nasdaq Corbus Pharmaceuticals Holdings, Inc. 2830
CRDL Nasdaq Cardiol Therapeutics Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CSLLY Over the counter CSL Limited 2830
CTMX Nasdaq CytomX Therapeutics, Inc. 2830
CTOR Nasdaq Citius Oncology, Inc. 2830
CTXR Nasdaq Citius Pharmaceuticals, Inc. 2830
CUE Nasdaq Cue Biopharma, Inc. 2830
CURX Nasdaq Curanex Pharmaceuticals Inc 2830
CVM NYSE American CEL-SCI Corporation 2830
CYCN Nasdaq Cyclerion Therapeutics, Inc. 2830
DERM Nasdaq Journey Medical Corporation 2830
DFTX Nasdaq Definium Therapeutics, Inc. 2830
DNLI Nasdaq Denali Therapeutics Inc. 2830
DRMA Nasdaq Dermata Therapeutics, Inc. 2830
DTIL Nasdaq Precision BioSciences, Inc. 2830
DWTX Nasdaq Dogwood Therapeutics, Inc. 2830
DYAI Nasdaq Dyadic International, Inc. 2830
EBS New York Emergent BioSolutions Inc. 2830
EDIT Nasdaq Editas Medicine, Inc. 2830
EDSA Nasdaq Edesa Biotech, Inc. 2830
EIKN Nasdaq Eikon Therapeutics, Inc. 2830
ELAN New York Elanco Animal Health Incorporated 2830
ELOX Nasdaq Eloxx Pharmaceuticals, Inc. 2830
ENGN Nasdaq enGene Therapeutics Inc. 2830
ENLV Nasdaq Enlivex Ltd. 2830
ENSC Nasdaq Ensysce Biosciences, Inc. 2830
EOLS Nasdaq Evolus, Inc. 2830
ESAIY Over the counter Eisai Co., Ltd. 2830
ESLA Nasdaq Estrella Immunopharma, Inc. 2830
ETON Nasdaq Eton Pharmaceuticals, Inc. 2830
EVGN Nasdaq Evogene Ltd. 2830
EWTX Nasdaq Edgewise Therapeutics, Inc. 2830
EYPT Nasdaq EyePoint, Inc. 2830
Results 50 through 100 of 269